|
Patient Info Information for Patients
Patients should be provided the REMICADE Patient Information Sheet and provided an opportunity to read it prior to each treatment infusion session. Because caution should be exercised in administering REMICADE to patients with clinically important active infections, it is important that the patient's overall health be assessed at each treatment visit and any questions resulting from the patient's reading of the Patient Information Sheet be discussed. Patient Information Sheet Text Continues Below

You should read this information sheetbefore you start using REMICADE¤(pronounced rem-eh-kaid) and before eachtime you are scheduled to receive REMICADE. This information sheet does not take the place of talking with your doctor. You and your doctor should talk about your health and how you are feeling before you start taking REMICADE,while you are taking it, and at regular checkups. If you do not understand any of the information in this sheet, you should ask your doctor to explain what it means. What is REMICADE? REMICADE is a medicine that is used to treat adults with moderately to severely active rheumatoid arthritis and Crohn’sdisease. In Crohn’s disease, REMICADE is for people who have not responded well enough to other medicines. How does REMICADE work? The medicine REMICADE is a type of protein that recognizes, attaches to, and blocks the action of a substance in your body called tumor necrosis factor. Tumornecrosis factor (TNF) is made by certain blood cells in your body. REMICADE will not cure rheumatoid arthritis or Crohn’sdisease, but blocking TNF with REMICADE may reduce the inflammation caused by too much TNF in your body. You should also know that REMICADE may help you feel better but can also cause serious side effects and can reduce your body’s ability to fight infections (see below). Page: 1 | 2 | 3 | 4 | 5 | Next >>
|